MS and the EU
The "Cross-border healthcare" Directive, entered into force on 25 October 2013, gives European citizens the right to receive medical treatment across the EU, and to be reimbursed for it.
The new Directive introduces three major changes focusing on patients' rights, according to the European Commission:
Firstly, citizens have the right to choose and be reimbursed for treatment, either public health care or private health care, anywhere in the EU.
Secondly, prior authorisations for cross-border healthcare will become the exception rather than the rule.
Finally, citizens have the right to make informed decisions about treatment options. They entitled to receive any relevant information from national contact points, established under the new Directive, and information from health care and treatment providers directly.
The "2nd European MS Awareness Day" organised by the European MS Platform (EMSP) at the European Parliament in Brussels on 21 November 2006 was extremely successful and effective.
The EP interest in MS and MS research is increasing. An overview on ongoing EU activities relating to MS is available.
Chairman of the Petitions Committee, Marcin Libicki, asked the Commission what has been done to implement the "Code" since the EP resolution in 2003.